---
category: news
title: "Novo Nordisk, Microsoft Collaborate on Drug Discovery Using AI"
excerpt: "The multi-year collaboration started with two use cases, including a large literature analysis and atherosclerosis risk prediction."
publishedDateTime: 2022-09-12T17:58:00Z
originalUrl: "https://www.mddionline.com/artificial-intelligence/novo-nordisk-microsoft-collaborate-drug-discovery-using-ai"
webUrl: "https://www.mddionline.com/artificial-intelligence/novo-nordisk-microsoft-collaborate-drug-discovery-using-ai"
type: article
quality: 34
heat: 34
published: false

provider:
  name: MD&M East
  domain: mddionline.com

topics:
  - AI
  - Microsoft AI

related:
  - title: "Mi­crosoft sinks deep­er in­to drug AI, inks col­lab with di­a­betes gi­ant No­vo Nordisk"
    excerpt: "It now appears that Microsoft wants to take on diabetes. In its latest foray into the drugmaking world, the tech giant has signed a pact with Novo Nordisk, one of the three major insulin manufacturers."
    publishedDateTime: 2022-09-12T14:32:00Z
    webUrl: "https://endpts.com/microsoft-sinks-deeper-into-drug-ai-inks-collab-with-diabetes-giant-novo-nordisk/"
    type: article
    provider:
      name: ENDPOINTS NEWS
      domain: endpts.com
    quality: 8
  - title: "Novo Nordisk A/S: Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence"
    excerpt: "Bagsværd, Denmark and Redmond, WA, US, 12 September 2022 - Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft's computational services, cloud and artificial"
    publishedDateTime: 2022-09-12T11:09:00Z
    webUrl: "https://www.finanznachrichten.de/nachrichten-2022-09/57032398-novo-nordisk-a-s-novo-nordisk-and-microsoft-collaborate-to-accelerate-drug-discovery-and-development-using-big-data-and-artificial-intelligence-399.htm"
    type: article
    provider:
      name: Finanznachrichten
      domain: finanznachrichten.de
    quality: 0

secured: "FRcD81QiuMLh7BIJls4QAoUrHPgXauapQVsLyFV7OUYJDnrPAwii2pEHcQImoaxSqqpOTqTz44V7ETcwOQaYcHWaVxuk10Aj4aRSVkAYrqSAo8BDsr3dPn5E8rH4xml+IqtA4UtudXsi9CVH3ZAonW7Kbd4Qkax/2IcxSKc8UXk/7uFvyWptQRjQQUAOXuto5UxA78iXfIhNPwXCPPzCFmako1aFDWajUgXf9iw7c6TcbGiJi51hftNprFWF8LL/8SES3v511NUV5ip/OeSsBfVgn5MZdcJ/Z6L6QOW/CXrQ2Pddw0vExaN7hR0G4w+DlX69tjPbPNXa8Z/i2XupwDkijL/zq/KGVMJ13xp6qwaA5J1Pb6iafHRMQVBnddgz3/g2plxWSQu5/dNTIBtIWsnghCH3c/Xivm5zuawUKYUPPqOhz6RZQnIyYM6girBFhaLmgKQJiZ0Ltg/sn/Ae7+tQQqv6cLeFsguOcLJpqN5q3iUfkAxbHQ/YuYTlALnxVIFsgOlHllNfHAubLUnW4Q==;neQJNSLvo04R1Pb20TIXWA=="
---

